These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32362605)

  • 1. Evaluation of growth factor independence 1 expression in patients with
    Salarpour F; Goudarzipour K; Mohammadi MH; Ahmadzadeh A; Faraahi S; Allahbakhshian A; Farsani MA
    J Cancer Res Ther; 2020; 16(1):23-27. PubMed ID: 32362605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of low PU.1 expression in patients with acute promyelocytic leukemia.
    Zhu X; Zhang H; Qian M; Zhao X; Yang W; Wang P; Zhang J; Wang K
    J Hematol Oncol; 2012 May; 5():22. PubMed ID: 22569057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-650 exerts anti-leukemia activity by inhibiting cell proliferation through Gfi1 targeting.
    Yuan C; Xu L; Du P; Pang J
    Tumori; 2018 Oct; 104(5):369-374. PubMed ID: 28574132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enforced GFI1 expression impedes human and murine leukemic cell growth.
    Hönes JM; Thivakaran A; Botezatu L; Patnana P; Castro SVDC; Al-Matary YS; Schütte J; Fischer KBI; Vassen L; Görgens A; Dührsen U; Giebel B; Khandanpour C
    Sci Rep; 2017 Nov; 7(1):15720. PubMed ID: 29147018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.
    Abramowitz J; Neuman T; Perlman R; Ben-Yehuda D
    BMC Med Genomics; 2017 Mar; 10(1):18. PubMed ID: 28340577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.
    Khandanpour C; Thiede C; Valk PJ; Sharif-Askari E; Nückel H; Lohmann D; Horsthemke B; Siffert W; Neubauer A; Grzeschik KH; Bloomfield CD; Marcucci G; Maharry K; Slovak ML; van der Reijden BA; Jansen JH; Schackert HK; Afshar K; Schnittger S; Peeters JK; Kroschinsky F; Ehninger G; Lowenberg B; Dührsen U; Möröy T
    Blood; 2010 Mar; 115(12):2462-72. PubMed ID: 20075157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature.
    Volpe G; Walton DS; Grainger DE; Ward C; Cauchy P; Blakemore D; Coleman DJL; Cockerill PN; Garcia P; Frampton J
    Sci Rep; 2017 Sep; 7(1):11148. PubMed ID: 28894287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cells.
    Patnana PK; Liu L; Frank D; Nimmagadda SC; Behrens M; Ahmed H; Xie X; Liebmann M; Wei L; Gerdemann A; Thivakaran A; Humpf HU; Klotz L; Dugas M; Varghese J; Trajkovic-Arsic M; Siveke JT; Hanenberg H; Opalka B; Dührsen U; Reinhardt HC; Guenther U; von Bubnoff N; Khandanpour C
    Br J Haematol; 2023 Sep; 202(5):1033-1048. PubMed ID: 37423893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
    Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
    BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML.
    Botezatu L; Michel LC; Helness A; Vadnais C; Makishima H; Hönes JM; Robert F; Vassen L; Thivakaran A; Al-Matary Y; Lams RF; Schütte J; Giebel B; Görgens A; Heuser M; Medyouf H; Maciejewski J; Dührsen U; Möröy T; Khandanpour C
    Exp Hematol; 2016 Aug; 44(8):713-726.e14. PubMed ID: 27216773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFI1 is required for
    Marneth AE; Botezatu L; Hönes JM; Israël JCL; Schütte J; Vassen L; Lams RF; Bergevoet SM; Groothuis L; Mandoli A; Martens JHA; Huls G; Jansen JH; Dührsen U; Berg T; Möröy T; Wichmann C; Lo MC; Zhang DE; van der Reijden BA; Khandanpour C
    Haematologica; 2018 Sep; 103(9):e395-e399. PubMed ID: 29674496
    [No Abstract]   [Full Text] [Related]  

  • 15. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
    Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
    Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.
    Chiarella E; Aloisio A; Scicchitano S; Todoerti K; Cosentino EG; Lico D; Neri A; Amodio N; Bond HM; Mesuraca M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
    Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
    Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of purine-rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication.
    Kelm RJ; Lamba GS; Levis JE; Holmes CE
    J Cell Biochem; 2018 Feb; 119(2):2073-2083. PubMed ID: 28834593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS).
    Xie X; Frank D; Patnana PK; Schütte J; Al-Matary Y; Liu L; Wei L; Dugas M; Varghese J; Nimmagadda SC; Khandanpour C
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GFI1 as a novel prognostic and therapeutic factor for AML/MDS.
    Hönes JM; Botezatu L; Helness A; Vadnais C; Vassen L; Robert F; Hergenhan SM; Thivakaran A; Schütte J; Al-Matary YS; Lams RF; Fraszscak J; Makishima H; Radivoyevitch T; Przychodzen B; da Conceição Castro SV; Görgens A; Giebel B; Klein-Hitpass L; Lennartz K; Heuser M; Thiede C; Ehninger G; Dührsen U; Maciejewski JP; Möröy T; Khandanpour C
    Leukemia; 2016 Jun; 30(6):1237-45. PubMed ID: 26847026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.